{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T14:40:53Z","timestamp":1725979253691},"reference-count":0,"publisher":"Managed Care and Healthcare Communications, LLC","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Manag Care"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.37765\/ajmc.2021.88592","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T22:35:54Z","timestamp":1612391754000},"page":"S3-S12","source":"Crossref","is-referenced-by-count":1,"title":["Updates in clinical data for FDA-approved disease-modifying therapies for spinal muscular atrophy"],"prefix":"10.37765","volume":"27","member":"24492","published-online":{"date-parts":[[2021,2,3]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T22:35:55Z","timestamp":1612391755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/updates-in-clinical-data-for-fda-approved-disease-modifying-therapies-for-spinal-muscular-atrophy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":0,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2021.88592","archive":["Portico"],"relation":{},"ISSN":["1936-2692","1088-0224"],"issn-type":[{"value":"1936-2692","type":"electronic"},{"value":"1088-0224","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}